Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-1999 | 03-1999 | 12-1998 | 09-1998 | 06-1998 | |
Sales | 2,341,600 | 2,255,600 | 2,635,400 | 2,573,200 | 2,340,700 |
Cost of Goods | 491,100 | 493,500 | 119,600 | 667,300 | 626,100 |
Gross Profit | 1,850,500 | 1,762,100 | 1,934,200 | 1,905,900 | 1,714,600 |
Operating Expenses | 1,110,200 | 1,006,500 | 1,272,200 | 1,122,400 | 1,072,900 |
Operating Income | 740,400 | 756,100 | 1,244,200 | 783,800 | 641,800 |
Interest Expense | 43,000 | 43,900 | 43,900 | 45,700 | 43,100 |
Other Income | 41,600 | -168,700 | -510,200 | -122,700 | 56,400 |
Pre-tax Income | 739,000 | 543,500 | 690,100 | 615,400 | 655,100 |
Income Tax | 162,600 | 92,100 | 131,600 | 97,200 | 163,800 |
Net Income Continuous | 576,400 | 451,400 | 561,600 | 518,200 | 491,300 |
Net Income Discontinuous | 0 | 174,300 | 5,700 | 0 | 0 |
Net Income | $576,400 | $625,700 | $567,300 | $518,200 | $491,300 |
EPS Basic Total Ops | 0.53 | 0.57 | 0.52 | 0.47 | 0.45 |
EPS Basic Continuous Ops | 0.53 | 0.41 | 0.51 | 0.47 | 0.45 |
EPS Basic Discontinuous Ops | N/A | 0.16 | 0.01 | N/A | N/A |
EPS Diluted Total Ops | 0.52 | 0.56 | 0.51 | 0.46 | 0.44 |
EPS Diluted Continuous Ops | 0.53 | 0.40 | 0.50 | 0.46 | 0.45 |
EPS Diluted Discontinuous Ops | N/A | 0.16 | 0.01 | N/A | N/A |
EBITDA(a) | $852,400 | $868,500 | $1,375,800 | $906,200 | $759,000 |